Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.34

€0.34

-3.320%
-0.0115
-3.320%
€1.38
 
25.03.24 / Tradegate WKN: A3DZ0T / Symbol: PALI / Name: Palisade Bio / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Palisade Bio Inc. Stock

Palisade Bio Inc. took a tumble today and lost -€0.012 (-3.320%).
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Palisade Bio Inc. is rather balanced.
With a target price of 1 € there is potential for a 195.42% increase which would mean more than doubling the current price of 0.34 € for Palisade Bio Inc..
Our community identified positive and negative aspects for Palisade Bio Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Palisade Bio Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Palisade Bio Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Palisade Bio Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Palisade Bio Inc. -3.320% -0.441% -7.640% -78.019% -41.130% -99.915% -99.999%
Gritstone Oncology Inc -6.610% -4.678% -6.857% 6.722% 31.593% -73.850% -
Rockwell Medical Inc. 1.330% 9.901% 25.121% -6.386% -12.795% -85.658% -97.163%
Innoviva Inc. 0.700% 2.899% -0.699% 36.538% -2.740% 42.000% -

Comments

Prediction Buy
Perf. (%) -38.23%
Target price 1.379
Change
Ends at 17.11.24

Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
Ratings data for PALI provided by MarketBeat
Show more

Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for PALI provided by MarketBeat
Show more

Sell Seneca Biopharma Inc.
Show more